Toggle navigation
Home
Search
Services
Blog
Contact
About
Post Exposure Prophylaxis Against HIV 1 by CD4 IGG2
Maddon, Paul J.
Progenics Pharmaceuticals, Inc., Tarrytown, NY, United States
Search 24 grants from Paul Maddon
Search grants from Progenics Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Regulation of a novel epigenome of protein biosynthesis genes
Nanophase Ceramics as Bone Implant Coatings
SBE: Option: Small: Safety for the Ages: Generational Differences in Motivations to Use Security Protections in an Online Banking Context
Transforming Web-based Courseware into a Full Statics Course with Digital Feedback and Assessment that Inform Interactive Classroom Activities
Metabolic Function of Protein - Lipid Interaction
Recently added grants:
Role of fibrinogen in Alzheimer's disease
The role of inhibitory microcircuits in the neural control of breathing
Network Properties of Circadian Clock Modulation and Entrainment
Understanding the molecular mechanisms that maintain excitation-inhibition balance in neural circuits
Molecular Mechanisms Underlying Obesity-related Memory Deficits
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AI036818-02
Application #
2004162
Study Section
Special Emphasis Panel (ZRG5-ARRA (01))
Project Start
1996-09-30
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Progenics Pharmaceuticals, Inc.
Department
Type
DUNS #
945494490
City
Tarrytown
State
NY
Country
United States
Zip Code
10591
Related projects
NIH 1997
R44 AI
Post Exposure Prophylaxis Against HIV 1 by CD4 IGG2
Maddon, Paul J. / Progenics Pharmaceuticals, Inc.
NIH 1996
R44 AI
Post Exposure Prophylaxis Against HIV 1 by CD4 IGG2
Maddon, Paul J. / Progenics Pharmaceuticals, Inc.
Comments
Be the first to comment on Paul Maddon's grant